Is Strides Pharma Science stock a buy?

Yes, Strides Pharma Science pays dividends. Last time was Friday 25th of October 2024 where the investors holding the stock on Monday 9th of September 2024 were paid INR2.5 per share. Over the last 17 times between 2010 and 2024, Strides Pharma Science has paid INR654 with an average of INR38.47 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Strides Pharma Science 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR398.80, you would have made a profit of INR960.95 per share or 240.96%

Yes, the average daily trading liquidity for Strides Pharma Science is INR420 975 thousand. You should therefore be able to get in and out of your positions relatively fast.

Strides Pharma Science has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.14, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Strides Pharma Science to be medium [0.6 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.